MCA Confirms cGMP at INEOS Fluor's ZEPHEX 227ea Plant
21 Mar 2002
The UK Medicines Control Agency (MCA) has confirmed that the INEOS Fluor ZEPHEX 227ea manufacturing facility, operated by joint venture partner Great Lakes Chemical Corporation in Arkansas, USA, is in compliance with current Good Manufacturing Practice (cGMP) at the standard required for the manufac